Related Experiment Video
Updated: Jun 16, 2025

Activated Cross-linked Agarose for the Rapid Development of Affinity Chromatography Resins - Antibody Capture as a Case Study
Published on: August 16, 2019
Enhancing monoclonal antibody stability during protein a chromatography using 2-methyl imidazolium dihydrogen
Ranjeet Desai1, Rahul Jaiswal2, Triveni Manchekar2
1Department of Pharmaceutical Sciences and Technology, Institute of Chemical Technology, Mumbai 400019, India; Department of Biological Sciences and Biotechnology, Institute of Chemical Technology, Mumbai 400019, India.
Abstract:
This study investigates the impact of 2-methyl imidazolium dihydrogen phosphate (2-MIDHP) on monoclonal antibody (mAb) aggregation during the Protein A purification stage, at a low pH (pH 3.0), and the viral inactivation phase. Size-exclusion high-performance liquid chromatography (SE-HPLC) and dynamic light scattering (DLS) were used to assess the mAb aggregation. Additionally, the influence of 2-MIDHP on mAb recovery, host cell protein (HCP) clearance, and Protein A leaching was investigated. Thermal stability of mAb, eluted in buffers containing 5 % to 25 % 2-MIDHP was analysed, using differential scanning calorimetry (DSC). Structural insights were obtained via circular dichroism (CD) and fluorescence spectroscopy. Our findings indicated that 2-MIDHP exerted a concentration-dependent protective effect against mAb aggregation, at the pH of 3.0. As the concentration of 2-MIDHP was increased from 0 % to 25 %, the aggregation was significantly reduced from 3.8 ± 0.01 % to 0.56 ± 0.002 %, as analysed by SE-HPLC. Addition of 2-MIDHP did not significantly impact the mAb recovery, HCP clearance, or Protein A leaching. DSC data supported these results, with higher 2-MIDHP concentrations leading to increased melting temperatures of mAb. CD and fluorescence spectroscopy revealed no significant changes in the secondary structure or aromatic residue environment in 2-MIDHP-treated samples, despite the observed reduction in aggregation. The results suggested that 2-MIDHP mitigated mAb aggregation during Protein A purification, possibly by stabilizing the protein structure under acidic stress conditions. These findings offer valuable insights for improving the robustness of mAb purification processes, enhancing product quality and yield.
Insights
2-methyl imidazolium dihydrogen phosphate (2-MIDHP) significantly reduces monoclonal antibody (mAb) aggregation during Protein A purification at low pH. This additive enhances mAb stability without negatively impacting recovery or purity during bioprocessing.
Area of Science:
- Biopharmaceutical Manufacturing
- Protein Chemistry
- Process Development
Background:
- Monoclonal antibody (mAb) aggregation is a critical issue during downstream processing, potentially compromising product quality and efficacy.
- Low pH conditions, often employed in Protein A chromatography and viral inactivation, can exacerbate mAb instability and promote aggregation.
- Developing strategies to mitigate aggregation under these stressed conditions is crucial for robust biomanufacturing.
Purpose of the Study:
- To investigate the impact of 2-methyl imidazolium dihydrogen phosphate (2-MIDHP) on mAb aggregation during Protein A purification at low pH.
- To evaluate the effect of 2-MIDHP on mAb recovery, host cell protein (HCP) clearance, and Protein A leaching.
- To assess the influence of 2-MIDHP on mAb thermal stability and structural integrity.
Main Methods:
- Size-exclusion high-performance liquid chromatography (SE-HPLC) and dynamic light scattering (DLS) were used to quantify mAb aggregation.
- Differential scanning calorimetry (DSC) was employed to analyze mAb thermal stability.
- Circular dichroism (CD) and fluorescence spectroscopy were utilized to probe mAb structural changes.
Main Results:
- 2-MIDHP demonstrated a concentration-dependent protective effect against mAb aggregation at pH 3.0, reducing aggregation from 3.8% to 0.56% with increasing concentrations.
- No significant adverse effects were observed on mAb recovery, HCP clearance, or Protein A leaching.
- DSC, CD, and fluorescence spectroscopy indicated that 2-MIDHP enhanced mAb thermal stability and maintained protein structure without causing denaturation.
Conclusions:
- 2-MIDHP effectively mitigates mAb aggregation during low pH Protein A purification, likely by stabilizing the antibody structure.
- The use of 2-MIDHP presents a promising strategy for improving the robustness and efficiency of mAb purification processes.
- These findings contribute to enhancing the quality and yield of therapeutic monoclonal antibodies.
Related Concept Videos
Affinity Chromatography
Immunoprecipitation
Chromatin Immunoprecipitation
Chromatin immunoprecipitation, also known as ChIP, is used to study protein-DNA or...
Hybridoma Technology
Hybridoma Selection
Commonly used fusion techniques — electroporation,...

